[Treatment with intravenous immunoglobulin in neurological diseases. A descriptive study of effects seen from the patient's and health services' perspectives].
Wintzell
Anne
A
Apoteket AB Sjukhusapoteket, Universitetssjukhuset i Lund.
Eriksson
Tommy
T
Lundgren
Anders
A
Petersson
Jesper
J
D001291:Attitude of Health Personnel; D020274:Autoimmune Diseases of the Nervous System / Q000188:drug therapy; D003362:Cost-Benefit Analysis; D005500:Follow-Up Studies; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D009422:Nervous System Diseases / Q000188:drug therapy*; D017060:Patient Satisfaction; D012307:Risk Factors; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous